相关实验视频
Updated: Jun 11, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
全球新生儿糖尿病:更新至2024年
Fabrizio Barbetti1, Asma Deeb2, Shigeru Suzuki3
1Monogenic Diabetes Clinic, Endocrinology and Diabetes Unit, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
Journal of diabetes investigation
|September 30, 2024
概括
新生儿糖尿病 (NDM) 是一种罕见的遗传疾病. 最近的发现已经将NDM基因列表扩展到40多个,突出了各种疾病机制和治疗需求.
科学领域:
- 遗传学 是一个遗传学.
- 内分泌学 在内分泌学.
- 儿科 儿科 儿科
背景情况:
- 新生儿糖尿病 (NDM) 是一种罕见的,单一的糖尿病形式,在生命的前六个月内出现.
- 自从20世纪90年代末首次发现以来,NDM的遗传景观已经大幅扩大.
- 目前正在进行的研究继续确定新的遗传原因,并完善对NDM病理生理学的理解.
研究的目的:
- 提供关于新生儿糖尿病研究近期进展的全面概述.
- 要突出NDM相关基因及其影响的日益扩大的列表.
- 讨论各种疾病机制和NDM不断发展的治疗策略.
主要方法:
- 基因测序和突变分析以确定导致NDM的基因.
- 使用先进的干细胞技术,包括诱导多能干细胞 (iPSC) 和人类胚胎干细胞 (hESC).
- 采用基因组编辑技术,如CRISPR用于NDM基因的功能研究.
主要成果:
- 在2018年至2024年初期间,发现了6种新的NDM基因 (CNOT1,FICD,ONECUT1,PDIA6,YIPF5,ZNF808).
- 三个已知的与疾病相关的基因 (EIF2B1,NARS2,KCNMA1) 和三个儿童糖尿病基因 (AGPAT2,BSCL2,PIK3R1) 也被确定为与NDM相关的.
- 鉴定到的NDM基因的总数现在超过了40个,这强调了显著的遗传异质性.
结论:
- 越来越多的NDM基因揭示了各种各样的致病机制.
- 像iPSC和CRISPR这样的最先进的方法对于调查NDM至关重要.
- 遗传多样性需要为NDM患者量身定制和多样化的治疗方法.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Pathophysiology of Diabetes
894
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
894
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications
515
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
515
Diabetes: Management and Pharmacotherapy
243
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
243
Hypoglycemia and Glucagon
206
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
206

